Fig. 1: Heat map of the PAC-1 screening results for multiple signaling pathways or targets.

The activity of PAC-1 in pathway assays was expressed as the activation rate relative to the positive compound (100 μM BP in the HIF1α pathway and 10 μM camptothecin in the RAD51 pathway) and negative control (0.2% DMSO)